Risk stratification for postoperative pancreatic fistula using the pancreatic surgery registry StuDoQ|Pancreas of the German Society for General and Visceral Surgery.


Journal

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
ISSN: 1424-3911
Titre abrégé: Pancreatology
Pays: Switzerland
ID NLM: 100966936

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 21 05 2018
revised: 02 09 2018
accepted: 16 11 2018
pubmed: 20 12 2018
medline: 23 4 2019
entrez: 20 12 2018
Statut: ppublish

Résumé

Postoperative pancreatic fistula (POPF) is a major factor for morbidity and mortality after pancreatic resection. Risk stratification for POPF is important for adjustment of treatment, selection of target groups in trials and quality assessment in pancreatic surgery. In this study, we built a risk-prediction model for POPF based on a large number of predictor variables from the German pancreatic surgery registry StuDoQ|Pancreas. StuDoQ|Pancreas was searched for patients, who underwent pancreatoduodenectomy from 2014 to 2016. A multivariable logistic regression model with elastic net regularization was built including 66 preoperative und intraoperative parameters. Cross-validation was used to select the optimal model. The model was assessed via area under the ROC curve (AUC) and calibration slope and intercept. A total of N = 2488 patients were included. In the optimal model the predictors selected were texture of the pancreatic parenchyma (soft versus hard), body mass index, histological diagnosis pancreatic ductal adenocarcinoma and operation time. The AUC was 0.70 (95% CI 0.69-0.70), the calibration slope 1.67 and intercept 1.12. In the validation set the AUC was 0.65 (95% CI 0.64-0.66), calibration slope and intercept were 1.22 and 0.42, respectively. The model we present is a valid measurement instrument for POPF risk based on four predictor variables. It can be applied in clinical practice as well as for risk-adjustment in research studies and quality assurance in surgery.

Sections du résumé

BACKGROUND BACKGROUND
Postoperative pancreatic fistula (POPF) is a major factor for morbidity and mortality after pancreatic resection. Risk stratification for POPF is important for adjustment of treatment, selection of target groups in trials and quality assessment in pancreatic surgery. In this study, we built a risk-prediction model for POPF based on a large number of predictor variables from the German pancreatic surgery registry StuDoQ|Pancreas.
METHODS METHODS
StuDoQ|Pancreas was searched for patients, who underwent pancreatoduodenectomy from 2014 to 2016. A multivariable logistic regression model with elastic net regularization was built including 66 preoperative und intraoperative parameters. Cross-validation was used to select the optimal model. The model was assessed via area under the ROC curve (AUC) and calibration slope and intercept.
RESULTS RESULTS
A total of N = 2488 patients were included. In the optimal model the predictors selected were texture of the pancreatic parenchyma (soft versus hard), body mass index, histological diagnosis pancreatic ductal adenocarcinoma and operation time. The AUC was 0.70 (95% CI 0.69-0.70), the calibration slope 1.67 and intercept 1.12. In the validation set the AUC was 0.65 (95% CI 0.64-0.66), calibration slope and intercept were 1.22 and 0.42, respectively.
CONCLUSION CONCLUSIONS
The model we present is a valid measurement instrument for POPF risk based on four predictor variables. It can be applied in clinical practice as well as for risk-adjustment in research studies and quality assurance in surgery.

Identifiants

pubmed: 30563791
pii: S1424-3903(18)30755-5
doi: 10.1016/j.pan.2018.11.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-25

Investigateurs

Carsten Crones (C)
Frank Klammer (F)
Matthias Anthuber (M)
Merten Hommann (M)
Klaus Prenzel (K)
Johann Pratschke (J)
Eric P M Lorenz (EPM)
Waldemar Uhl (W)
Jörg C Kalff (JC)
Ute Tröbs (U)
Helmut Witzigmann (H)
Hans-Jörg Krämling (HJ)
Albrecht Stier (A)
Robert Grützmann (R)
Marco Niedergethmann (M)
Matthias Schwarzbach (M)
Wolf Otto Bechstein (WO)
Thomas Kraus (T)
Stefan Fichtner-Feigl (S)
Michael Kindler (M)
Thomas Manger (T)
Winfried Padberg (W)
Michael Ghadimi (M)
Karl-Jürgen Oldhafer (KJ)
Ansgar Michael Chromik (AM)
Nurettin Albayrak (N)
Matthias Glanemann (M)
Christian Mönch (C)
Hans-Bernd Reith (HB)
Christiane Bruns (C)
Anton J Kroesen (AJ)
Sven Eisold (S)
Tobias Keck (T)
Ullrich Fleck (U)
Stefan Post (S)
Detlef Bartsch (D)
Carsten Gutt (C)
Jens Werner (J)
Natascha Nüssler (N)
Helmut Friess (H)
Norbert Senninger (N)
Hubert Stein (H)
Franz-Josef Schumacher (FJ)
Dietmar Lorenz (D)
Pompiliu Piso (P)
Ernst Klar (E)
Jörg-Peter Ritz (JP)
Jörg Köninger (J)
Norbert Runkel (N)
Elke Wagler (E)
Christoph Jacobi (C)
Stefan Farkas (S)
Mark Jäger (M)
Christoph-Thomas Germer (CT)

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Ekaterina Petrova (E)

Department of Surgery, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

Hryhoriy Lapshyn (H)

Department of Surgery, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

Dirk Bausch (D)

Department of Surgery, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

Jan D'Haese (J)

Department of General, Visceral, and Transplant Surgery, University Hospital Munich, LMU, Munich, Germany.

Jens Werner (J)

Department of General, Visceral, and Transplant Surgery, University Hospital Munich, LMU, Munich, Germany.

Thomas Klier (T)

Klinik für Allgemein-, Viszeralchirurgie und endokrine Chirurgie, Städtisches Klinikum München GmbH, Klinikum Neuperlach, Munich, Germany.

Natascha C Nüssler (NC)

Klinik für Allgemein-, Viszeralchirurgie und endokrine Chirurgie, Städtisches Klinikum München GmbH, Klinikum Neuperlach, Munich, Germany.

Jochen Gaedcke (J)

Klinik für Allgemein-, Viszeral- und Kinderchirurgie, Universitätsmedizin Göttingen, Göttingen, Germany.

Michael Ghadimi (M)

Klinik für Allgemein-, Viszeral- und Kinderchirurgie, Universitätsmedizin Göttingen, Göttingen, Germany.

Waldemar Uhl (W)

St. Josef-Hospital Bochum, Department of Surgery, Hospital of the Ruhr-University, Bochum, Germany.

Orlin Belyaev (O)

St. Josef-Hospital Bochum, Department of Surgery, Hospital of the Ruhr-University, Bochum, Germany.

Olga Kantor (O)

University of Chicago, Department of Surgery, Chicago, IL, USA.

Marshall Baker (M)

Associate Professor of Surgery at Loyola University, Stritch School of Medicine, Maywood, IL, USA.

Tobias Keck (T)

Department of Surgery, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. Electronic address: tobias.keck@uksh.de.

Ulrich F Wellner (UF)

Department of Surgery, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH